Latest Headlines

  1. OptraSCAN To Introduce HER2 Scan + Analyze Pilot At CAP 2025 9/9/2025

    OptraSCAN, a leader in digital pathology and AI-powered diagnostics, today announced the launch of its HER2 Scan + Analyze Quantitative Solution Pilot Program at the College of American Pathologists (CAP) 2025 - The Pathologists’ Meeting, running September 13-16 in Orlando, Florida.

  2. Sapio Sciences And Ultima Genomics Partner To Advance Multi-Omics Research 9/9/2025

    Sapio Sciences, the science-aware lab informatics platform, today announced a strategic partnership with Ultima Genomics.

  3. Henry Schein Medical Expands SolutionsHub With Colaborate 9/9/2025

    Henry Schein Medical, the U.S. medical business of Henry Schein, Inc., has expanded its SolutionsHub™ with the addition of Colaborate, a full-service management consulting firm dedicated to serving independent and hospital-based medical laboratories.

  4. Panome Bio Advances Clinical Discovery With First Metabolomics Workflow For Formalin-Fixed Paraffin-Embedded (FFPE) Samples 9/9/2025

    Panome Bio, a leading provider of multi-omic services, announced a first of its kind commercial offering applying their leading discovery metabolomics capabilities to Formalin-Fixed Paraffin-Embedded (FFPE) samples.

  5. Philips Announces Digital Pathology Scanner With Native, Configurable DICOM JPEG And JPEG XL Output In World First 9/8/2025

    Pathology plays a crucial role in the diagnosis of a variety of diseases, particularly cancer, through examination of patient tissue samples.

  6. Roche Receives CE IVDR Approval For HER2 (4B5) Companion Diagnostic Test To Identify HER2-Ultralow Breast Cancer And Biliary Tract Cancer Patients 9/5/2025

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received CE IVDR approval for two label expansions for its VENTANA® HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx* assay.

  7. GeodAIsics And HORIBA Partner To Develop AI-Powered Sepsis Detection Solution 9/4/2025

    GeodAIsics, an AI-driven healthcare startup, and HORIBA ABX SAS, one of the group companies of HORIBA, a leader in measurement and test solutions for applications across various business fields, have announced a strategic partnership to develop an GenAI-powered software solution for early sepsis detection.

  8. diaago Expands Automation Offering Through Partnership With PAA, Introducing The KX-2 Collaborative Robot 9/4/2025

    diaago, a stocking distributor of laboratory consumables and equipment, has added innovations from Peak Analysis & Automation (PAA) to its automation portfolio, marking another strategic partnership to support the growing need for versatile automation solutions.

  9. Mass General Brigham Launches Genetic Test Developed In Collaboration With Broad Clinical Labs To Predict Risk Across Eight Cardiovascular Conditions 9/3/2025

    In a step forward for genomic-driven preventive medicine, Mass General Brigham Personalized Medicine and the Massachusetts General Hospital's Cardiovascular Disease Prevention Center and Center for Genomic Medicine today announced the launch of an innovative genetic test designed to estimate an individual's inherited risk for eight chronic cardiovascular conditions.

  10. Arima Genomics Introduces Aventa Lymphoma Test To Resolve Diagnostic Uncertainty In B- And T-Cell Lymphomas 9/3/2025

    Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced the broad commercial launch of the Aventa Lymphoma test at the Society of Hematologic Oncology (SOHO 2025) meeting in Houston, Texas.